SHS

SHS Capital is a healthcare-dedicated private equity fund based in Tübingen, Germany. Founded in 1993, they focus on investing in fast-growing companies in the healthcare sector with the mission to build European healthcare champions. They provide capital, access to their extensive network built over 30 years, and expertise in market access, reimbursement, marketing/sales, M&A, and exit strategies. SHS invests in innovative companies, including SMEs and scale-up companies, with a preference for those with seven-digit revenues and double-digit growth rates. They are flexible in their investment approach, considering both majority and minority positions. SHS Capital looks for companies with cutting-edge technologies improving healthcare standards, defensible and scalable market positions, and high-performing management teams with innovative mindsets. They aim to support these companies in achieving substantial growth and becoming leaders in their respective fields. The firm emphasizes a collaborative partnership approach, leveraging their deep industry knowledge and network to help portfolio companies navigate the complexities of the healthcare market. SHS Capital's geographic focus is primarily the DACH region (Germany, Austria, Switzerland), the Nordics, and Benelux countries, but they selectively consider opportunities in other European countries. They consider transactions with enterprise values of up to EUR 150 million and typically invest equity tickets in the range of EUR 10-50 million. They seek ways of potential partnerships through their investor site and welcome collaboration with scientists, entrepreneurs, and investors in the healthcare network.

Medical devices, diagnostics, life sciences, specialty pharmaceuticals, healthcare services, digital health, pharma and life science automation

Core thematic spaces, technologies, and target market segments of interest.